ID   GCYB1_HUMAN             Reviewed;         619 AA.
AC   Q02153; B7Z426; Q86WY5;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1993, sequence version 1.
DT   10-MAY-2017, entry version 163.
DE   RecName: Full=Guanylate cyclase soluble subunit beta-1;
DE            Short=GCS-beta-1;
DE            EC=4.6.1.2 {ECO:0000269|PubMed:1352257, ECO:0000269|PubMed:23505436, ECO:0000269|PubMed:24669844};
DE   AltName: Full=Guanylate cyclase soluble subunit beta-3 {ECO:0000303|PubMed:1352257};
DE            Short=GCS-beta-3;
DE   AltName: Full=Soluble guanylate cyclase small subunit;
GN   Name=GUCY1B3; Synonyms=GUC1B3, GUCSB3, GUCY1B1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, ENZYME
RP   REGULATION, SUBUNIT, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=1352257; DOI=10.1016/0014-5793(92)80594-7;
RA   Giuili G., Scholl U., Bulle F., Guellaeen G.;
RT   "Molecular cloning of the cDNAs coding for the two subunits of soluble
RT   guanylyl cyclase from human brain.";
RL   FEBS Lett. 304:83-88(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM HSGC-2).
RC   TISSUE=Kidney;
RA   Gansemans Y., Brouckaert P., Fiers W.;
RL   Submitted (AUG-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM HSGC-1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 337-545, AND ALTERNATIVE SPLICING.
RC   TISSUE=Lung;
RX   PubMed=1680753; DOI=10.1016/0014-5793(91)81248-7;
RA   Chhajilani V., Fraendberg P.-A., Ahlner J., Axelsson K.L.,
RA   Wikberg J.E.S.;
RT   "Heterogeneity in human soluble guanylate cyclase due to alternative
RT   splicing.";
RL   FEBS Lett. 290:157-158(1991).
RN   [7] {ECO:0000244|PDB:2WZ1, ECO:0000244|PDB:3UVJ}
RP   X-RAY CRYSTALLOGRAPHY (1.63 ANGSTROMS) OF 408-619 IN COMPLEX WITH
RP   GUCY1A3, INTERACTION WITH GUCY1A3, SUBUNIT, CATALYTIC ACTIVITY, AND
RP   ENZYME REGULATION.
RX   PubMed=23505436; DOI=10.1371/journal.pone.0057644;
RA   Allerston C.K., von Delft F., Gileadi O.;
RT   "Crystal structures of the catalytic domain of human soluble guanylate
RT   cyclase.";
RL   PLoS ONE 8:E57644-E57644(2013).
RN   [8] {ECO:0000244|PDB:4NI2}
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 408-608 IN COMPLEX WITH
RP   GUCY1A3, INTERACTION WITH GUCY1A3, CATALYTIC ACTIVITY, AND SUBUNIT.
RX   PubMed=24669844; DOI=10.1021/bi500129k;
RA   Seeger F., Quintyn R., Tanimoto A., Williams G.J., Tainer J.A.,
RA   Wysocki V.H., Garcin E.D.;
RT   "Interfacial residues promote an optimal alignment of the catalytic
RT   center in human soluble guanylate cyclase: heterodimerization is
RT   required but not sufficient for activity.";
RL   Biochemistry 53:2153-2165(2014).
CC   -!- FUNCTION: Mediates responses to nitric oxide (NO) by catalyzing
CC       the biosynthesis of the signaling molecule cGMP.
CC       {ECO:0000250|UniProtKB:P16068, ECO:0000269|PubMed:1352257}.
CC   -!- CATALYTIC ACTIVITY: GTP = 3',5'-cyclic GMP + diphosphate.
CC       {ECO:0000269|PubMed:1352257}.
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC         Evidence={ECO:0000250|UniProtKB:P16068};
CC       Note=Binds 1 or 2 heme groups per heterodimer. Heme is required
CC       for responding to nitric oxide, but not for catalytic activity.
CC       {ECO:0000250|UniProtKB:P16068};
CC   -!- ENZYME REGULATION: Activated by nitric oxide in the presence of
CC       magnesium or manganese ions. {ECO:0000269|PubMed:1352257}.
CC   -!- SUBUNIT: The active enzyme is formed by a heterodimer of an alpha
CC       and a beta subunit. Heterodimer with GUCY1A3 (PubMed:1352257,
CC       PubMed:23505436, PubMed:24669844). Can also form inactive
CC       homodimers in vitro (PubMed:23505436, PubMed:24669844).
CC       {ECO:0000269|PubMed:23505436, ECO:0000269|PubMed:24669844}.
CC   -!- INTERACTION:
CC       Q02108:GUCY1A3; NbExp=2; IntAct=EBI-6911707, EBI-3910037;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P16068}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=HSGC-1;
CC         IsoId=Q02153-1; Sequence=Displayed;
CC       Name=HSGC-2;
CC         IsoId=Q02153-2; Sequence=VSP_001813;
CC       Name=3;
CC         IsoId=Q02153-3; Sequence=VSP_054365;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Detected in brain cortex and cerebellum (at
CC       protein level). {ECO:0000269|PubMed:1352257}.
CC   -!- MISCELLANEOUS: There are two types of guanylate cyclases: soluble
CC       forms and membrane-associated receptor forms.
CC   -!- SIMILARITY: Belongs to the adenylyl cyclase class-4/guanylyl
CC       cyclase family. {ECO:0000255|PROSITE-ProRule:PRU00099}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X66533; CAA47144.1; -; mRNA.
DR   EMBL; AF020340; AAB94877.1; -; mRNA.
DR   EMBL; AK296680; BAH12412.1; -; mRNA.
DR   EMBL; AC114761; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC047620; AAH47620.2; -; mRNA.
DR   CCDS; CCDS47154.1; -. [Q02153-1]
DR   CCDS; CCDS77976.1; -. [Q02153-2]
DR   CCDS; CCDS77977.1; -. [Q02153-3]
DR   PIR; S23097; S23097.
DR   RefSeq; NP_000848.1; NM_000857.3. [Q02153-1]
DR   RefSeq; NP_001278881.1; NM_001291952.1. [Q02153-3]
DR   RefSeq; NP_001278882.1; NM_001291953.1.
DR   RefSeq; NP_001278883.1; NM_001291954.1. [Q02153-2]
DR   UniGene; Hs.77890; -.
DR   PDB; 2WZ1; X-ray; 1.63 A; A/B=408-619.
DR   PDB; 3UVJ; X-ray; 2.08 A; B/D=408-619.
DR   PDB; 4NI2; X-ray; 1.90 A; B=408-608.
DR   PDBsum; 2WZ1; -.
DR   PDBsum; 3UVJ; -.
DR   PDBsum; 4NI2; -.
DR   ProteinModelPortal; Q02153; -.
DR   SMR; Q02153; -.
DR   BioGrid; 109238; 15.
DR   IntAct; Q02153; 2.
DR   STRING; 9606.ENSP00000264424; -.
DR   BindingDB; Q02153; -.
DR   ChEMBL; CHEMBL3137281; -.
DR   GuidetoPHARMACOLOGY; 1290; -.
DR   iPTMnet; Q02153; -.
DR   PhosphoSitePlus; Q02153; -.
DR   BioMuta; GUCY1B3; -.
DR   DMDM; 399328; -.
DR   MaxQB; Q02153; -.
DR   PaxDb; Q02153; -.
DR   PeptideAtlas; Q02153; -.
DR   PRIDE; Q02153; -.
DR   Ensembl; ENST00000264424; ENSP00000264424; ENSG00000061918. [Q02153-1]
DR   Ensembl; ENST00000503520; ENSP00000420842; ENSG00000061918. [Q02153-2]
DR   Ensembl; ENST00000505764; ENSP00000426319; ENSG00000061918. [Q02153-3]
DR   GeneID; 2983; -.
DR   KEGG; hsa:2983; -.
DR   UCSC; uc003ipc.4; human. [Q02153-1]
DR   CTD; 2983; -.
DR   DisGeNET; 2983; -.
DR   GeneCards; GUCY1B3; -.
DR   HGNC; HGNC:4687; GUCY1B3.
DR   HPA; CAB010890; -.
DR   HPA; HPA020870; -.
DR   MIM; 139397; gene.
DR   neXtProt; NX_Q02153; -.
DR   OpenTargets; ENSG00000061918; -.
DR   PharmGKB; PA29068; -.
DR   eggNOG; KOG4171; Eukaryota.
DR   eggNOG; COG2114; LUCA.
DR   GeneTree; ENSGT00760000118959; -.
DR   HOGENOM; HOG000220903; -.
DR   HOVERGEN; HBG051715; -.
DR   InParanoid; Q02153; -.
DR   KO; K12319; -.
DR   PhylomeDB; Q02153; -.
DR   TreeFam; TF351403; -.
DR   Reactome; R-HSA-392154; Nitric oxide stimulates guanylate cyclase.
DR   SIGNOR; Q02153; -.
DR   EvolutionaryTrace; Q02153; -.
DR   GeneWiki; GUCY1B3; -.
DR   GenomeRNAi; 2983; -.
DR   PRO; PR:Q02153; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000061918; -.
DR   CleanEx; HS_GUCY1B3; -.
DR   ExpressionAtlas; Q02153; baseline and differential.
DR   Genevisible; Q02153; HS.
DR   GO; GO:0008074; C:guanylate cyclase complex, soluble; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004383; F:guanylate cyclase activity; IDA:UniProtKB.
DR   GO; GO:0020037; F:heme binding; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004872; F:receptor activity; TAS:ProtInc.
DR   GO; GO:0008015; P:blood circulation; TAS:ProtInc.
DR   GO; GO:0071732; P:cellular response to nitric oxide; ISS:UniProtKB.
DR   GO; GO:0006182; P:cGMP biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0007263; P:nitric oxide mediated signal transduction; TAS:ProtInc.
DR   GO; GO:0038060; P:nitric oxide-cGMP-mediated signaling pathway; ISS:UniProtKB.
DR   Gene3D; 3.30.70.1230; -; 1.
DR   InterPro; IPR001054; A/G_cyclase.
DR   InterPro; IPR018297; A/G_cyclase_CS.
DR   InterPro; IPR011644; Heme_NO-bd.
DR   InterPro; IPR011645; HNOB_dom_associated.
DR   InterPro; IPR024096; NO_sig/Golgi_transp_ligand-bd.
DR   InterPro; IPR029787; Nucleotide_cyclase.
DR   Pfam; PF00211; Guanylate_cyc; 1.
DR   Pfam; PF07700; HNOB; 1.
DR   Pfam; PF07701; HNOBA; 1.
DR   SMART; SM00044; CYCc; 1.
DR   SUPFAM; SSF111126; SSF111126; 1.
DR   SUPFAM; SSF55073; SSF55073; 1.
DR   PROSITE; PS00452; GUANYLATE_CYCLASE_1; 1.
DR   PROSITE; PS50125; GUANYLATE_CYCLASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; cGMP biosynthesis;
KW   Complete proteome; Cytoplasm; Direct protein sequencing; GTP-binding;
KW   Heme; Iron; Lyase; Metal-binding; Nucleotide-binding;
KW   Reference proteome.
FT   CHAIN         1    619       Guanylate cyclase soluble subunit beta-1.
FT                                /FTId=PRO_0000074116.
FT   DOMAIN      421    554       Guanylate cyclase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00099}.
FT   METAL       105    105       Iron (heme proximal ligand).
FT                                {ECO:0000250|UniProtKB:P16068}.
FT   VAR_SEQ       1     26       MYGFVNHALELLVIRNYGPEVWEDIK -> MLMCFI (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054365.
FT   VAR_SEQ     393    425       Missing (in isoform HSGC-2).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_001813.
FT   STRAND      415    427       {ECO:0000244|PDB:2WZ1}.
FT   HELIX       430    436       {ECO:0000244|PDB:2WZ1}.
FT   HELIX       443    461       {ECO:0000244|PDB:2WZ1}.
FT   TURN        463    465       {ECO:0000244|PDB:2WZ1}.
FT   STRAND      470    472       {ECO:0000244|PDB:2WZ1}.
FT   STRAND      479    487       {ECO:0000244|PDB:2WZ1}.
FT   HELIX       492    507       {ECO:0000244|PDB:2WZ1}.
FT   STRAND      519    533       {ECO:0000244|PDB:2WZ1}.
FT   STRAND      535    537       {ECO:0000244|PDB:2WZ1}.
FT   STRAND      539    544       {ECO:0000244|PDB:2WZ1}.
FT   HELIX       545    555       {ECO:0000244|PDB:2WZ1}.
FT   STRAND      561    565       {ECO:0000244|PDB:2WZ1}.
FT   HELIX       566    571       {ECO:0000244|PDB:2WZ1}.
FT   TURN        575    577       {ECO:0000244|PDB:2WZ1}.
FT   STRAND      582    590       {ECO:0000244|PDB:2WZ1}.
FT   STRAND      599    607       {ECO:0000244|PDB:2WZ1}.
SQ   SEQUENCE   619 AA;  70514 MW;  231E4E660DE02AA1 CRC64;
     MYGFVNHALE LLVIRNYGPE VWEDIKKEAQ LDEEGQFLVR IIYDDSKTYD LVAAASKVLN
     LNAGEILQMF GKMFFVFCQE SGYDTILRVL GSNVREFLQN LDALHDHLAT IYPGMRAPSF
     RCTDAEKGKG LILHYYSERE GLQDIVIGII KTVAQQIHGT EIDMKVIQQR NEECDHTQFL
     IEEKESKEED FYEDLDRFEE NGTQESRISP YTFCKAFPFH IIFDRDLVVT QCGNAIYRVL
     PQLQPGNCSL LSVFSLVRPH IDISFHGILS HINTVFVLRS KEGLLDVEKL ECEDELTGTE
     ISCLRLKGQM IYLPEADSIL FLCSPSVMNL DDLTRRGLYL SDIPLHDATR DLVLLGEQFR
     EEYKLTQELE ILTDRLQLTL RALEDEKKKT DTLLYSVLPP SVANELRHKR PVPAKRYDNV
     TILFSGIVGF NAFCSKHASG EGAMKIVNLL NDLYTRFDTL TDSRKNPFVY KVETVGDKYM
     TVSGLPEPCI HHARSICHLA LDMMEIAGQV QVDGESVQIT IGIHTGEVVT GVIGQRMPRY
     CLFGNTVNLT SRTETTGEKG KINVSEYTYR CLMSPENSDP QFHLEHRGPV SMKGKKEPMQ
     VWFLSRKNTG TEETKQDDD
//
